Last reviewed · How we verify
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder (OCD) - Pilot Study
The purpose of the study is to evaluate the efficacy of quetiapine or placebo added to baseline treatment of SSRI/clomipramine for the treatment of OCD in adult subjects.
Details
| Lead sponsor | AstraZeneca |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 44 |
| Start date | 2002-04 |
| Completion | 2006-03 |
Conditions
- Obsessive Compulsive Disorder
Interventions
- quetiapine fumarate
- SSRI/Clomipramine
Primary outcomes
- Absolute change of OCD symptoms from baseline to endpoint on the total Y-BOCS score.
Countries
Germany